Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $5.0750 (3.57%) ($4.6800 - $5.2500) on Thu. May. 14, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 9.97% (three month average) | RSI | 70 | Latest Price | $5.0750(3.57%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 4.9% a day on average for past five trading days. | Weekly Trend | BCRX advances 21% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) IBB(10%) XLV(9%) CEMB(7%) ONLN(7%) DRIV(6%) | Factors Impacting BCRX price | BCRX will decline at least -4.985% in a week (0% probabilities). IYT(-5%) URA(-4%) JETS(-4%) UUP(-3%) TAN(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -4.985% (StdDev 9.97%) | Hourly BBV | -0.6 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $5.12(-0.88%) | 10 Day Moving Average | $4.51(12.53%) | 20 Day Moving Average | $4.01(26.56%) | To recent high | -8% | To recent low | 0% | Market Cap | $895m | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |